Physician profile
Mark Hochman
NPI 1710109426
$5,060,310.60
in general payments reported to CMS, 2019-2025
6 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559K · 2020: $782K · 2021: $208K · 2022: $599K · 2023: $652K · 2024: $1.1M · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.5M · Consulting Fee: $440K · Travel and Lodging: $6,607 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,232 · Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,459,812.12 |
| Consulting Fee | $439,999.98 |
| Travel and Lodging | $6,606.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,232.05 |
| Food and Beverage | $104.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Milestone Scientific INC. | $5,060,095.79 | 2019-2025 | |
| Align Technology, INC. | $90.10 | 2020 | |
| Southern Implants North America INC | $44.85 | 2019 | |
| Zimvie INC. | $38.95 | 2022 | |
| Dentsply Sirona INC | $29.00 | 2024 | Nupro |
| Philips North America LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$297,313.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hochman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.